Last edition
News about "pharmaceutical manufacturing compliance"
Lupin Receives US FDA EIR for Ankleshwar Manufacturing Facility
Lupin has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Ankleshwar facility following the successful closure of a product-specific pre-approval inspection conducted in March 2026.
Pharmaceutical Manufacturing Compliance | 28/05/2026 | By News Bureau
Piramal Pharma Completes US FDA Inspection at Lexington Facility
Piramal Pharma receives US FDA EIR with VAI status for its Lexington facility, marking successful closure of inspection and regulatory compliance.
Pharmaceutical Manufacturing Compliance | 13/04/2026 | By News Bureau | 195
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy